These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28325946)

  • 1. Epigenetically regulated Fibronectin leucine rich transmembrane protein 2 (FLRT2) shows tumor suppressor activity in breast cancer cells.
    Bae H; Kim B; Lee H; Lee S; Kang HS; Kim SJ
    Sci Rep; 2017 Mar; 7(1):272. PubMed ID: 28325946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FLRT2 functions as Tumor Suppressor gene inactivated by promoter methylation in Colorectal Cancer.
    Guo X; Song C; Fang L; Li M; Yue L; Sun Q
    J Cancer; 2020; 11(24):7329-7338. PubMed ID: 33193897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc-finger protein 331, a novel putative tumor suppressor, suppresses growth and invasiveness of gastric cancer.
    Yu J; Liang QY; Wang J; Cheng Y; Wang S; Poon TC; Go MY; Tao Q; Chang Z; Sung JJ
    Oncogene; 2013 Jan; 32(3):307-17. PubMed ID: 22370639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FLRT2 promotes cellular proliferation and inhibits cell adhesion during chondrogenesis.
    Xu Y; Wei K; Kulyk W; Gong SG
    J Cell Biochem; 2011 Nov; 112(11):3440-8. PubMed ID: 21769912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
    Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
    Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of TUSC5 genes in breast cancer tissue.
    Bubnov V; Moskalev E; Petrovskiy Y; Bauer A; Hoheisel J; Zaporozhan V
    Exp Oncol; 2012 Dec; 34(4):370-2. PubMed ID: 23302999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
    Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
    Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OASIS/CREB3L1 is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration in vitro.
    Rose M; Schubert C; Dierichs L; Gaisa NT; Heer M; Heidenreich A; Knüchel R; Dahl E
    Epigenetics; 2014 Dec; 9(12):1626-40. PubMed ID: 25625847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide profiling in melatonin-exposed human breast cancer cell lines identifies differentially methylated genes involved in the anticancer effect of melatonin.
    Lee SE; Kim SJ; Yoon HJ; Yu SY; Yang H; Jeong SI; Hwang SY; Park CS; Park YS
    J Pineal Res; 2013 Jan; 54(1):80-8. PubMed ID: 22856590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.
    Wang F; Feng Y; Li P; Wang K; Feng L; Liu YF; Huang H; Guo YB; Mao QS; Xue WJ
    Oncotarget; 2016 Jan; 7(4):4279-97. PubMed ID: 26701853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The highly expressed 5'isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration.
    Salem O; Erdem N; Jung J; Münstermann E; Wörner A; Wilhelm H; Wiemann S; Körner C
    BMC Genomics; 2016 Aug; 17():566. PubMed ID: 27502506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line.
    Buchegger K; Ili C; Riquelme I; Letelier P; Corvalán AH; Brebi P; Huang TH; Roa JC
    Biol Res; 2016 Jan; 49():5. PubMed ID: 26796959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer.
    Heller G; Geradts J; Ziegler B; Newsham I; Filipits M; Markis-Ritzinger EM; Kandioler D; Berger W; Stiglbauer W; Depisch D; Pirker R; Zielinski CC; Zöchbauer-Müller S
    Breast Cancer Res Treat; 2007 Jul; 103(3):283-91. PubMed ID: 17260099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-Wide Methylation Analysis Identifies NOX4 and KDM5A as Key Regulators in Inhibiting Breast Cancer Cell Proliferation by Ginsenoside Rg3.
    Ham J; Lee S; Lee H; Jeong D; Park S; Kim SJ
    Am J Chin Med; 2018; 46(6):1333-1355. PubMed ID: 30149757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of DBCCR1 as a suppressor in the development of lung cancer that is associated with increased DNA methyltransferase 1.
    Zhou G; Ye J; Fang Y; Zhang Z; Zhang J; Sun L; Feng J
    Oncotarget; 2017 May; 8(20):32821-32832. PubMed ID: 28427182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human homolog of Drosophila expanded, hEx, functions as a putative tumor suppressor in human cancer cell lines independently of the Hippo pathway.
    Visser-Grieve S; Hao Y; Yang X
    Oncogene; 2012 Mar; 31(9):1189-95. PubMed ID: 21785462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of EZH2 reactivates RASSF2A by reversal of promoter methylation in breast cancer cells.
    Yu P; Guo Y; Yusufu M; Liu Z; Wang S; Yin X; Peng G; Wang L; Zhao X; Guo H; Huang T; Liu C
    Cell Biol Int; 2016 Oct; 40(10):1062-70. PubMed ID: 27436059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CERS2 suppresses tumor cell invasion and is associated with decreased V-ATPase and MMP-2/MMP-9 activities in breast cancer.
    Fan SH; Wang YY; Lu J; Zheng YL; Wu DM; Zhang ZF; Shan Q; Hu B; Li MQ; Cheng W
    J Cell Biochem; 2015 Apr; 116(4):502-13. PubMed ID: 25213553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.